Clinical Research

Should patients on semaglutide increase their dose or try tirzepatide? A real-world look at cardiovascular outcomes
A new analysis found that one approach may outperform the other when it comes to minimizing the patient's risk of major cardiovascular events.
Laser IVL system for CAD impresses in first-in-human study
FastWave Medical's laser intravascular lithotripsy system successfully fractured calcified coronary artery lesions in 30 patients.
Scientists identify a potential new treatment for vascular dementia
“Patients are in desperate need of an effective treatment, and we are doing everything we can to help find that treatment,” one scientist explained. “The greatest reward would be to see a safe and effective treatment for people who currently have very few options.”
Government-funded program wants better AI for managing heart failure in the US
The long-term goal is to bring 24-7 cardiac care to every American, even those living in counties with no cardiologists.
Acoramidis bests tafamidis in head-to-head comparison of ATTR-CM drugs
Acoramidis was associated with a 43% lower risk of diuretic intensification and a 34% lower risk of clinical worsening overall.

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

Semaglutide’s health benefits may be linked to dose rather than weight loss

Tracking 12,519 cardiology patients taking semaglutide found a 58% lower risk of all-cause mortality.

NIH spends $88M on radiology research, but specialty still represents small share of pie

New data reveal that clinician investigators consistently represented a minority of NIH-funded researchers in medical imaging.

Video: Amanda Randles, PhD, director of the Duke Center for Computational and Digital Health Innovation, and professor of biomedical engineering, explains how her lab created a digital twin technology that can take patient imaging and data to recreate a digital model of the patient's coronary blood flow. The computational platform called HARVEY can simulate a patient's hemodynamics so accurately, it may eliminate the need for invasive coronary FFR pressure wires to diagnose heart disease.

Duke's digital twin technology could take hemodynamic assessments to a whole other level

Researchers at Duke are hard at work on digital twins that could help care teams make important treatment decisions.

artificial intelligence AI in healthcare

Stanford researchers land NIH grant to advance intraoperative molecular imaging technique

The team is looking to advance the development of a molecular imaging agent that can guide lung cancer surgery in real time.

Clopidogrel monotherapy bests aspirin when patients with diabetes undergo PCI

After an initial period of DAPT, what's the best next step? A new analysis reviewed data from the SMART-CHOICE 3 clinical trial.

New PARTNER 3 update links TAVR to early benefits over SAVR

Low-risk patients face comparable outcomes after TAVR and SAVR, researchers wrote, making it important to highlight even the smallest differences between these two approaches.

Researchers bag $7M grant to study specialized MRI technique for lymphatic disease

The team hopes the technique could provide an objective way to identify clinical concerns earlier by assessing sodium buildup in affected tissues before severe swelling develops.

Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).

Abbott gathering real-world data on FDA-approved TriClip system

Abbott's TriClip system for tricuspid regurgitation is approved by the FDA and covered by Medicare. To learn more about its real-world performance, researchers will now track 1,000 patients for a total of five years.

Clinical Research

Should patients on semaglutide increase their dose or try tirzepatide? A real-world look at cardiovascular outcomes

Laser IVL system for CAD impresses in first-in-human study

Scientists identify a potential new treatment for vascular dementia

Government-funded program wants better AI for managing heart failure in the US

Acoramidis bests tafamidis in head-to-head comparison of ATTR-CM drugs